Hubal MJ, Devaney JM, Hoffman EP, Zambraski EJ, Gordish-Dressman H, Kearns AK, Larkin JA, Adham K, Patel RR, Clarkson PM. CCL2 and CCR2 polymorphisms are associated with markers of exercise-induced skeletal muscle damage. J Appl Physiol. 2010 Jun;108(6):1651-8.
Gardala M, Kearns AK, Thompson PD. Efficacy of Rosuvastatin (5 mg and 10 mg) twice a week in patients intolerant to daily statins. Am J Cardiol. 2008 Jun 15;101(12):1747-8.
Kearns AK, Bilbie CL, Clarkson PM, White CM, Sewright KA, O’Fallon KS, Gardarla M, Thompson PD. The Creatine Kinase Response to Eccentric Exercise with Atorvastatin 10mg or 80mg. Atherosclerosis. 2008 Sept;200(1):121-5.
Sewright K, Kearns AK, Hubal MJ, Clarkson PM. Sex Differences in Response to Maximal Eccentric Exercise. Med. Sci. Sports Exerc. 2008 Feb;40(2):242-51.
Devaney JM, Hoffman EP, Gordish-Dressman H, Kearns A, Zambraski E, Clarkson PM. IGF-II gene region polymorphisms related to exertional muscle damage. J Appl Physiol. 2007 May;102(5):1815-23.
Clarkson, PM, Kearns AK, Rouzier P, Rubin R, Thompson PD. Serum creatine kinase levels and renal function measures in exertional muscle damage. Med Sci Sport Ex. 2006 April ;38(4):623-7.